Clinical Trials Logo

Citation(s)

A Phase 1 Dose-Escalation Study of SCH 900776 as Monotherapy and in Combination With Gemcitabine in Subjects With Advanced Solid Tumors or Lymphoma

Details for clinical trial NCT00779584